Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013


Streamlining Routine Chromatography Analyses using eWorkflows

12 Dec 2013 - 12 Dec 2013 - Webinar, 8:00am PST / 4:00pm GMT / 5:00pm CET / 11:00am EST



Bookmark and Share


Live Webcast:
Thursday, December 12, 2013
8:00am PST / 4:00pm GMT / 5:00pm CET / 11:00am EST

Event Overview 
When setting up a chromatography analysis it is often a requirement tofollow guidelines, like a standard operating procedure (SOP), for sequence creation, sample analysis and result calculation. But how do you ensure the rules of the SOPs are being routinely followed, especially during method transfer between laboratories? There are many areas where manual sequence creation can cause errors. 

This web seminar will showcase how the eWorkflows™ feature within the Thermo Scientific™ Dionex™ Chromeleon™ 7 Chromatography Data System (CDS) software provides a simple template for the fast creation of complete, correct sequences with pre-defined method and reportfiles and well-defined structures. We will demonstrate how eWorkflows have 
been applied in the Chromeleon Extension Pack to a routine application: USP 34 / EP 5.2 / BP2011 - Uniformity of Dosage Units. 

Learn how eWorkflows minimizes the amount of training required to run any analysis, safeguard method transfer, and take you from samples to reliable results in a minimum number of steps.

Key Learning Objectives 
• Chromeleon CDS is the most modern, gold standard CDS from Thermo Scientific with intelligent functionality, saving you time and money
• The Chromeleon Extension Pack provides eWorkflow templates for common routine analyses
• How eWorkflows can simplify reliable sequence creation and method transfer

Speaker
darrenbarrington-light.gif

Darren Barrington-Light, Product Specialist, Thermo Scientific




Moderator
: Ashley Board Ph. D., Managing Editor, Technology Networks



Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
Crystal Clear Images Uncover Secrets of Hormone Receptors
NIH researchers gain better understanding of how neuropeptide hormones trigger chemical reactions in cells.
New Tool Uses 'Drug Spillover' to Match Cancer Patients with Treatments
Researchers have developed a new tool that improves the ability to match drugs to disease: the Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best "kinase inhibitor" to silence these dangerous genetic causes of disease.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!